AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15994985 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial reports stating ethical approval obtained
Number of subjects: 155
Study 15994985 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial reports indicating informed consent obtained
Number of subjects: 155
Study 12168276 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation (HV) during Fiberoptic Bronchoscopy (FB)
Number of subjects: 34
Study 12168276 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HV) during Fiberoptic Bronchoscopy (FB)
Number of subjects: 34
Study 9738725 — intervention group
Group type: EXPERIMENTAL
Intervention: LAC formula (lactose as the sole carbohydrate)
Number of subjects: 6
Study 9738725 — intervention group
Group type: EXPERIMENTAL
Intervention: LAC formula
Number of subjects: 6
Study 9738725 — intervention group
Group type: COMPARATOR
Intervention: SC formula (standard preterm formula with 50% lactose)
Number of subjects: 6
Study 9738725 — intervention group
Group type: COMPARATOR
Intervention: SC formula
Number of subjects: 6
Study 8570447 — intervention group
Group type: EXPERIMENTAL
Intervention: Correctly placed IO needles (intramedullary)
Number of subjects: 12
Study 8570447 — intervention group
Group type: EXPERIMENTAL
Intervention: Incorrectly placed IO needles (extramedullary)
Number of subjects: 12
Study 2131900 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg of diphenhydramine 30 minutes prior to heparin administration (Group II)
Number of subjects: 200
Study 2131900 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg of cimetidine 4 hours and again 30 minutes before heparin administration (Group III)
Number of subjects: 200
Study 2131900 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg of diphenhydramine 30 minutes prior to heparin administration and 5 mg/kg of cimetidine 4 hours and 30 minutes before heparin administration (Group IV)
Number of subjects: 200
Study 2131900 — intervention group
Group type: COMPARATOR
Intervention: No histamine-receptor blockade (Group I - Control)
Number of subjects: 200
Study 388988 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofepramine
Number of subjects: 46
Study 388988 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 46
Study 31519267 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage Therapy (MT)
Number of subjects: 380
Study 31519267 — intervention group
Group type: COMPARATOR
Intervention: Simple Touch
Number of subjects: 380
Study 28456442 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150mg
Number of subjects: 48
Study 28456442 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300mg
Number of subjects: 48
Study 28456442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 25701335 — intervention group
Group type: EXPERIMENTAL
Intervention: Legume-enriched diet
Number of subjects: 26
Study 25701335 — intervention group
Group type: EXPERIMENTAL
Intervention: Legume-enriched diet (women subgroup)
Number of subjects: 26
Study 25701335 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet
Number of subjects: 26
Study 23289899 — intervention group
Group type: EXPERIMENTAL
Intervention: NWP06 (extended-release methylphenidate)
Number of subjects: 45
Study 23289899 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 21298377 — intervention group
Group type: EXPERIMENTAL
Intervention: Expression of p53, Ki-67 and c-Myc proteins in adjacent non-neoplastic mucosa
Number of subjects: 154
Study 21298377 — intervention group
Group type: EXPERIMENTAL
Intervention: Expression of p53, Ki-67 and c-Myc proteins in surgical margin mucosa
Number of subjects: 154
Study 21298377 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular markers (p53, Ki-67, c-Myc) for assessing surgical margin status
Number of subjects: 154
Study 19239556 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosmarinic acid (0.3%) emulsion applied topically twice a day (morning and evening)
Number of subjects: 21
Study 15925737 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavonoid-rich dark chocolate (100 g)
Number of subjects: 17
Study 12181083 — intervention group
Group type: EXPERIMENTAL
Intervention: huperzine Alpha 400 micro g/day for 12 weeks
Number of subjects: 202
Study 12181083 — intervention group
Group type: EXPERIMENTAL
Intervention: huperzine Alpha
Number of subjects: 202
Study 10506234 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxil
Number of subjects: 462
Study 10506234 — intervention group
Group type: COMPARATOR
Intervention: Penicillin V
Number of subjects: 462
Study 7594027 — intervention group
Group type: EXPERIMENTAL
Intervention: Arbutamine stress thallium-201 SPECT
Number of subjects: 184
Study 7594027 — intervention group
Group type: COMPARATOR
Intervention: Exercise stress thallium-201 SPECT
Number of subjects: 184
Study 7594027 — intervention group
Group type: EXPERIMENTAL
Intervention: Arbutamine and exercise stress testing
Number of subjects: 184
Study 7594027 — intervention group
Group type: EXPERIMENTAL
Intervention: Arbutamine
Number of subjects: 184
Study 2016620 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous human recombinant interferon beta (rIFN‐beta; Betaseron) given by IV infusion over 30 minutes 3 times per week (MWF) with dose escalation: 50-100-200, 100-200-400, 200-300-500, and 300-400-600 x 10(6) IU/m2.
Number of subjects: 29
Study 7326374 — intervention group
Group type: EXPERIMENTAL
Intervention: Specially designed prenatal care process or service (Groups 1 and 2)
Number of subjects: 108
Study 7326374 — intervention group
Group type: COMPARATOR
Intervention: Standard midwifery care and continuity of caregiver (Groups 3 and 4)
Number of subjects: 108
Study 7326374 — intervention group
Group type: COMPARATOR
Intervention: No continuity of caregiver or special treatment (Group 4)
Number of subjects: 108
Study 29952247 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (3 × 30‐s maximal cycle ergometer sprints against a resistance of 7.5% body weight, interspersed with 2 min of active recovery)
Number of subjects: 40
Study 29952247 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 40
Study 27902891 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized agility training in barefoot footwear
Number of subjects: 30
Study 27902891 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized agility training in minimal footwear
Number of subjects: 30
Study 27902891 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized agility training in traditional shoes
Number of subjects: 30
Study 26629989 — intervention group
Group type: EXPERIMENTAL
Intervention: Angled split virtual keyboard
Number of subjects: 18
Study 26629989 — intervention group
Group type: COMPARATOR
Intervention: Standard virtual keyboard
Number of subjects: 18
Study 26629989 — intervention group
Group type: COMPARATOR
Intervention: Wide virtual keyboard
Number of subjects: 18
Study 26629989 — intervention group
Group type: EXPERIMENTAL
Intervention: Usage position in bed
Number of subjects: 18
Study 26629989 — intervention group
Group type: EXPERIMENTAL
Intervention: Typing sessions
Number of subjects: 18
Study 26629989 — intervention group
Group type: EXPERIMENTAL
Intervention: Body discomfort rating
Number of subjects: 18
Study 26629989 — intervention group
Group type: EXPERIMENTAL
Intervention: Split keyboard design
Number of subjects: 18
Study 26629989 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide keyboard
Number of subjects: 18
Study 24557963 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition plus polyethylene glycol (Group 2)
Number of subjects: 108
Study 24557963 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition plus magnesium sulfate (Group 4)
Number of subjects: 108
Study 24557963 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol (Group 1)
Number of subjects: 108
Study 24557963 — intervention group
Group type: COMPARATOR
Intervention: Magnesium sulfate (Group 3)
Number of subjects: 108
Study 21291943 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (100-200 mg/day)
Number of subjects: 53
Study 21291943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 18928481 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide (NES) 72-hour infusion at 0.01 mcg/kg/min
Number of subjects: 19
Study 18928481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 18928481 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide (NES)
Number of subjects: 19
Study 16609069 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal triple therapy (MTX, cytarabine, and hydrocortisone sodium succinate)
Number of subjects: 2027
Study 16609069 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal methotrexate
Number of subjects: 2027
Study 14743074 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail-in specimen submission option
Number of subjects: 122
Study 14743074 — intervention group
Group type: COMPARATOR
Intervention: Clinic rescreening
Number of subjects: 122
Study 11471407 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified positioning according to Doppler sonography (84 patients)
Number of subjects: 160
Study 11471407 — intervention group
Group type: COMPARATOR
Intervention: Conventional figure-of-four positioning (76 patients)
Number of subjects: 160
Study 11471407 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 160
Study 9438893 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 2 micrograms/kg
Number of subjects: 122
Study 9438893 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9% (Control)
Number of subjects: 122
Study 8215479 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (3.0 mg/body) with methylprednisolone sodium (750 mg/body)
Number of subjects: 23
Study 8215479 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone sodium (750 mg/body) plus metoclopramide (46.7 mg/body on average) and domperidone (82.9 mg/body on average)
Number of subjects: 23
Study 2485052 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (LIS) 20-80 mg q.d., n = 10
Number of subjects: 15
Study 2485052 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (NIF) 20-40 mg b.i.d., n = 5
Number of subjects: 15
Study 29369493 — intervention group
Group type: EXPERIMENTAL
Intervention: DV3316 (shield-triggered pen-injector)
Number of subjects: 150
Study 29369493 — intervention group
Group type: COMPARATOR
Intervention: FlexPen (standard pen-injector)
Number of subjects: 150
Study 29369493 — intervention group
Group type: EXPERIMENTAL
Intervention: DV3316
Number of subjects: 150
Study 29369493 — intervention group
Group type: COMPARATOR
Intervention: FlexPen
Number of subjects: 150
Study 26842425 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured, moderate intensity physical activity program (n=818) conducted in a center (twice a week) and at home (3‐4 times a week) including aerobic, strength, flexibility, and balance training activities.
Number of subjects: 1635
Study 26842425 — intervention group
Group type: COMPARATOR
Intervention: Health education program (n=817) consisting of workshops on topics relevant to older people and upper extremity stretching exercises.
Number of subjects: 1635
Study 26842425 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured physical activity program (men)
Number of subjects: 1635
Study 26842425 — intervention group
Group type: COMPARATOR
Intervention: Health education program (women)
Number of subjects: 1635
Study 24504686 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2605541 (0.01‐2.22 U/kg)
Number of subjects: 41
Study 24504686 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine (0.5‐0.8 U/kg)
Number of subjects: 41
Study 24504686 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2605541 (SC)
Number of subjects: 41
Study 24504686 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine (SC)
Number of subjects: 41
Study 24504686 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2605541 (IV)
Number of subjects: 41
Study 24504686 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2605541
Number of subjects: 41
Study 22695363 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held circular coil
Number of subjects: 10
Study 22695363 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigated figure-of-eight coil
Number of subjects: 10
Study 22695363 — intervention group
Group type: EXPERIMENTAL
Intervention: Circular coil
Number of subjects: 10
Study 22695363 — intervention group
Group type: EXPERIMENTAL
Intervention: All coil systems (with outlier removed)
Number of subjects: 10
Study 20482960 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacoeducation module
Number of subjects: 82
Study 20482960 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study 18507948 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation with compressive plate
Number of subjects: 20
Study 18507948 — intervention group
Group type: EXPERIMENTAL
Intervention: Interlocking intramedullary nailing
Number of subjects: 20
Study 18507948 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannulated screws for femoral neck fractures
Number of subjects: 20
Study 18507948 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal femoral nail for fixing both neck and shaft
Number of subjects: 20
Study 18507948 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 20
Study 15730350 — intervention group
Group type: EXPERIMENTAL
Intervention: Reserpine 0.5 mg
Number of subjects: 60
Study 15730350 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 1800 mg
Number of subjects: 60
Study 15730350 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine 150 mg
Number of subjects: 60
Study 15730350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 14520213 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate removal of in‐dwelling catheter after operation
Number of subjects: 250
Study 14520213 — intervention group
Group type: COMPARATOR
Intervention: In‐dwelling catheter removed on the first day after operation
Number of subjects: 250
Study 10756218 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized budesonide 0.25 mg every 6 hours (group A)
Number of subjects: 71
Study 10756218 — intervention group
Group type: COMPARATOR
Intervention: Nebulized ipratropium bromide 0.1 mg every 6 hours (group B)
Number of subjects: 71
Study 9161235 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmon calcitonin (100 IU in 1 mL saline) administered three times per week for 3 weeks
Number of subjects: 13
Study 9161235 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 mL saline) administered three times per week for 3 weeks
Number of subjects: 13
Study 8339551 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg oral simvastatin daily for 2 years
Number of subjects: 383
Study 8339551 — intervention group
Group type: COMPARATOR
Intervention: Placebo daily for 2 years
Number of subjects: 383
Study 3485937 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (Group E)
Number of subjects: 30
Study 3485937 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group P)
Number of subjects: 30
Study 3485937 — intervention group
Group type: COMPARATOR
Intervention: Control (Group S)
Number of subjects: 30
Study 30189876 — intervention group
Group type: EXPERIMENTAL
Intervention: 21-day MPRRI program
Number of subjects: 388
Study 30189876 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list comparison (WLC)
Number of subjects: 388
Study 24120718 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. sugammadex 4 mg/kg with oral aspirin 75 mg
Number of subjects: 26
Study 24120718 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. sugammadex 4 mg/kg
Number of subjects: 26
Study 24120718 — intervention group
Group type: COMPARATOR
Intervention: i.v. placebo
Number of subjects: 26
Study 24120718 — intervention group
Group type: COMPARATOR
Intervention: i.v. placebo/sugammadex
Number of subjects: 26
Study 21418212 — intervention group
Group type: EXPERIMENTAL
Intervention: Hanen's 'More Than Words' (HMTW) intervention over 3.5 months
Number of subjects: 62
Study 21418212 — intervention group
Group type: EXPERIMENTAL
Intervention: Hanen's 'More Than Words' (HMTW) intervention
Number of subjects: 62
Study 21418212 — intervention group
Group type: COMPARATOR
Intervention: 'Business as usual' control group
Number of subjects: 62
Study 19344563 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual ketorolac (30 mg, three doses)
Number of subjects: 0
Study 19344563 — intervention group
Group type: COMPARATOR
Intervention: IV metamizole (1 g)
Number of subjects: 0
Study 17368263 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly developed laparoscopic morcellator
Number of subjects: 48
Study 17368263 — intervention group
Group type: COMPARATOR
Intervention: Existing laparoscopic morcellator
Number of subjects: 48
Study 15015612 — intervention group
Group type: EXPERIMENTAL
Intervention: sME HELIXOR A
Number of subjects: 224
Study 15015612 — intervention group
Group type: COMPARATOR
Intervention: Lentinan (Control)
Number of subjects: 224
Study 11292134 — intervention group
Group type: EXPERIMENTAL
Intervention: Employing a full-time data manager
Number of subjects: 0
Study 11292134 — intervention group
Group type: EXPERIMENTAL
Intervention: Employing a part-time data manager
Number of subjects: 0
Study 11292134 — intervention group
Group type: EXPERIMENTAL
Intervention: Data manager responsible for data quality
Number of subjects: 0
Study 11292134 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared responsibility for data quality
Number of subjects: 0
Study 9764063 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical amiodarone
Number of subjects: 132
Study 9764063 — intervention group
Group type: COMPARATOR
Intervention: Electrophysiologically guided treatment
Number of subjects: 132
Study 8141445 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam (1.2 mg.h‐1) + Fentanyl (1.2 mg.h‐1)
Number of subjects: 45
Study 8141445 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane (0.6‐1.2 vol%) + Fentanyl (1.2 mg.h‐1)
Number of subjects: 45
Study 8141445 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (4‐8 mg.kg‐1.h‐1) + Fentanyl (1.2 mg.h‐1)
Number of subjects: 45
Study 8141445 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 45
Study 3290709 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 98
Study 3290709 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone and Azathioprine combination therapy
Number of subjects: 98
Study 3290709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 31021890 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-dose preparation (4-L polyethylene glycol)
Number of subjects: 300
Study 31021890 — intervention group
Group type: COMPARATOR
Intervention: Same-day preparation (4-L polyethylene glycol)
Number of subjects: 300
Study 31021890 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowel preparation ≥7 hours before colonoscopy
Number of subjects: 300
Study 28219104 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (3×50 mg/day)
Number of subjects: 12
Study 28219104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 28219104 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril and Placebo
Number of subjects: 12
Study 26571023 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress reduction with the Transcendental Meditation technique and a basic health education course (SR)
Number of subjects: 48
Study 26571023 — intervention group
Group type: COMPARATOR
Intervention: Extensive health education program (EHE)
Number of subjects: 48
Study 23142441 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-injection femoral nerve block (FNB)
Number of subjects: 200
Study 23142441 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block (FNB)
Number of subjects: 200
Study 22017225 — intervention group
Group type: EXPERIMENTAL
Intervention: Beating Bipolar intervention
Number of subjects: 50
Study 22017225 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 50
Study 18664541 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg rhTSH
Number of subjects: 29
Study 18664541 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 21514190 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga poses (Cobra, Cat, and Fish Poses)
Number of subjects: 92
Study 21514190 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 92
Study 15910868 — intervention group
Group type: EXPERIMENTAL
Intervention: Molsidomine 16 mg once a day (o.a.d.)
Number of subjects: 172
Study 11823268 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 157
Study 11823268 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 157
Study 11823268 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 157
Study 11823268 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 157
Study 9572791 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 7
Study 9572791 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 7
Study 8574301 — intervention group
Group type: EXPERIMENTAL
Intervention: Teachers of singing
Number of subjects: 174
Study 8574301 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 174
Study 8574301 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydrating medications
Number of subjects: 174
Study 8574301 — intervention group
Group type: EXPERIMENTAL
Intervention: Past voice problem
Number of subjects: 174
Study 8574301 — intervention group
Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 174
Study 8574301 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger subjects
Number of subjects: 174
Study 2503020 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 20 mg sodium cromoglycate
Number of subjects: 6
Study 2503020 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep inspiration at 4 hours
Number of subjects: 6
Study 2503020 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 6
Study 367509 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg vancomycin six-hourly for five days
Number of subjects: 44
Study 367509 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 29337426 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CYC)
Number of subjects: 80